George R. Brown Convention Center

Lantern Pharma to Present Data Highlighting the Anti-Tumor Potency of Drug Candidate LP-284 in Non-Hodgkin’s Lymphomas at the Society of Hematologic Oncology Annual Meeting

Retrieved on: 
Thursday, August 31, 2023
Biotechnology, Pharmaceutical, Oncology, Health, Artificial Intelligence, Technology, Genetics, Clinical Trials, Society, Mantle cell lymphoma, George R. Brown Convention Center, NHL, SOHO, American Society of Pediatric Hematology/Oncology, Hematological Cancer Research Investment and Education Act, Machine learning, Lymphoma, Annual general meeting, Artificial intelligence, Poster, AI, IND, Pharmaceutical industry, Lantern

Lantern expects to initiate Phase 1 clinical trials for LP-284 during Q4 of 2023.

Key Points: 
  • Lantern expects to initiate Phase 1 clinical trials for LP-284 during Q4 of 2023.
  • Details of the poster presentation are listed below and can be found on the SOHO website .
  • A full version of the poster will be available on Lantern’s website on September 11, 2023.
  • Lantern’s LP-284 program has been accelerated and de-risked using AI insights and biological modeling powered by RADR®.

Photonis Expands Market-Leading Mass Spectrometry Detection Technology

Retrieved on: 
Tuesday, May 23, 2023
Microchannel plate detector, American Society for Mass Spectrometry, Partnership, ASMS, Mass spectrometry, A300, George R. Brown Convention Center, Quality of life, AC, MS, Research and development, Development, Investment, Research, Microchannel, Society, Conference, Bipolar, Medical imaging

Attendees are encouraged to meet and speak to the company's diverse team of technical experts and learn more about how their industry-leading MS Detection Technology will benefit new applications in Mass Spectrometry due to unprecedented performance levels.

Key Points: 
  • Attendees are encouraged to meet and speak to the company's diverse team of technical experts and learn more about how their industry-leading MS Detection Technology will benefit new applications in Mass Spectrometry due to unprecedented performance levels.
  • At this occasion, Photonis, the leaders in Time-of-Flight (TOF) detection technologies, will showcase their latest advancements in TOF detection with additions to their existing detector platforms - the APTOF and BPTOF Series.
  • Ulrich Laupper, President and General Manager of Photonis' Ultimate Detection Business Unit: "We are excited to introduce the next generation of Time-of-Flight detection technology at this year's ASMS Conference.
  • The APTOF A300 and BPTOF B380 provide mass spectrometry instrument manufacturers an unmatched cost-of-ownership value proposition.

Glytec Simplifies Glycemic Management for Clinicians and Pharmacists with New Glucommander® Enhancements

Retrieved on: 
Wednesday, August 2, 2023
Software, Research, Pharmaceutical, Data Management, Technology, Medical Devices, Infectious Diseases, Hospitals, Science, Nursing, FDA, Health, Diabetes, Hyperspace, Hyperglycemia, Insulin, CMS, IV, Face, Learning curve, George R. Brown Convention Center, Administration, Electronic health record, Pharmacist, Hospital, Hypoglycemia, E-GMS, MD, EHR, Patient, Patient safety, Risk, Medical device, Pharmaceutical industry, Glucommander

These innovations help streamline workflows, improve patient outcomes and offer tighter support for the industry’s top electronic health record (EHR) systems.

Key Points: 
  • These innovations help streamline workflows, improve patient outcomes and offer tighter support for the industry’s top electronic health record (EHR) systems.
  • More than 300 hospitals nationwide trust Glytec’s eGlycemic Management System® (eGMS®) to ensure safe and effective glycemic management for their patients.
  • “Glytec is leading the way to a future where every hospital across the country provides the highest quality glycemic care possible,” said Jordan Messler, MD, Chief Medical Officer at Glytec.
  • For a demo of Glucommander at ADCES23, visit the Glytec booth (#1915), or contact Glytec to schedule in advance at https://glytecsystems.com/contact-us/ .

Iterum Therapeutics to Present Data at ASM Microbe 2023

Retrieved on: 
Monday, June 12, 2023
IV, Infection, George R. Brown Convention Center, ASM, ITRM, CDT, Therapy, Pharmaceutical industry, Vaccine, Flour

DUBLIN, Ireland and CHICAGO, June 12, 2023 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (the Company), a clinical-stage pharmaceutical company focused on developing next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and hospital settings, today announced that three posters will be presented at ASM Microbe 2023 conference.

Key Points: 
  • DUBLIN, Ireland and CHICAGO, June 12, 2023 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (the Company), a clinical-stage pharmaceutical company focused on developing next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and hospital settings, today announced that three posters will be presented at ASM Microbe 2023 conference.
  • The hybrid conference will be held from June 15-19 at the George R. Brown Convention Center in Houston, TX.
  • Data to be presented include:
    Presentation type/category: P002-AAR01 Surveillance of antimicrobial resistance in clinical isolates; β-lactamases (AAR-Friday-410)
    Time/location: June 16, 2023, 10:00 a.m. – 5:00 p.m. CDT; Exhibit and Poster Hall B, C, D
    Presentation type/category: P002-AAR01 Surveillance of antimicrobial resistance in clinical isolates; β-lactamases (AAR-Friday-417)
    Time/location: June 16, 2023, 10:00 a.m. – 5:00 p.m. CDT; Exhibit and Poster Hall B, C, D
    Presentation type/category: P002-AAR01 Surveillance of antimicrobial resistance in clinical isolates; β-lactamases (AAR-Friday-401)
    Time/location: June 16, 2023, 10:00 a.m. – 5:00 p.m. CDT; Exhibit and Poster Hall B, C, D
    These Posters will be made available on the Company’s website on the “Publications: Posters & Presentations” page under the “Our Science” tab once the conference ends.

Paratek Pharmaceuticals Presenting New Data from NUZYRA® (omadacycline) and Investigator-Initiated Research Programs at ASM Microbe 2023

Retrieved on: 
Monday, June 12, 2023
Post-exposure prophylaxis, Public, Infection, George R. Brown Convention Center, ASM, Brain, Government, Immunodeficiency, Gram-positive bacteria, Skin, Vaccine, Paint, Nocardia

BOSTON, June 12, 2023 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel life-saving therapies for life-threatening diseases and other public health threats for civilian, government and military use, today announces that new data from studies with NUZYRA® (omadacycline) will be presented at ASM Microbe 2023 conference.

Key Points: 
  • BOSTON, June 12, 2023 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel life-saving therapies for life-threatening diseases and other public health threats for civilian, government and military use, today announces that new data from studies with NUZYRA® (omadacycline) will be presented at ASM Microbe 2023 conference.
  • The hybrid conference will be held June 15-19 at the George R. Brown Convention Center in Houston, TX.
  • View ASM Microbe scientific program here .
  • “Presentations at ASM Microbe provide data from two key studies that further explore the potential of NUZYRA as an option for the treatment and post-exposure prophylaxis in the event of an anthrax bioterror attack,” said Randy Brenner, chief development and regulatory officer of Paratek.

Pokatok Unveiled to Celebrate and Showcase Sports Around the World and the Technologies Transforming the Industry

Retrieved on: 
Wednesday, June 7, 2023
NCAA, Sport, 2011 NCAA Men's Basketball All-Americans, Greater Houston Partnership, George R. Brown Convention Center, Calendar, Discovery Green, Language, Sale, Athlete, College football national championships in NCAA Division I FBS, City, Black college football national championship, Houston First Corporation, Cricket World Cup, Houston Sports Park, Entertainment

HOUSTON, June 7, 2023 /PRNewswire/ -- Gow Companies announced today the coming of Pokatok™, a festival to bring the world together – nations, teams, athletes, communities, brands, innovators, and fans – for the "world's fair for sports." The four-day event will be held in Houston, Texas, on April 4-7, 2024.

Key Points: 
  • "Pokatok will not only be the largest gathering of the entire sports tech ecosystem, it will also be a true fan festival for sports enthusiasts," said Lawson Gow, Founder of Pokatok.
  • Houston is known as one of the best sports destinations in the world," said Harris County - Houston Sports Authority CEO Janis Burke.
  • Events like Pokatok are great for advancing sports within the region and providing unique opportunities for our community!"
  • From the first sport to the future of sport, Pokatok will be the world's gathering place for everything sport.

Thermo Fisher Scientific Showcases Solutions for Accelerating Biological Discovery

Retrieved on: 
Monday, June 5, 2023
Biotechnology, Technology, Other Health, Health, Pharmaceutical, Health Technology, Other Science, Medical Devices, Research, Software, Science, Astral, Vaccine, Data management, Maintenance, American Society for Mass Spectrometry, Therapy, ASMS, Mass spectrometry, George R. Brown Convention Center, Cancer, Chromatography, Chromatography software, Proteome, Web browser, Thermo Fisher Scientific, Biopharma LLC, Messenger, DDA, CDS, Protein, Acquisition, Algorithm, SP1, DIA, Society, Conference, Disease, Medical device, Computer data storage

Thermo Fisher Scientific is showcasing new mass spectrometry and chromatography instruments, software and workflows that enable customers to unlock deeper analytical insights, improve productivity and accelerate biological discovery.

Key Points: 
  • Thermo Fisher Scientific is showcasing new mass spectrometry and chromatography instruments, software and workflows that enable customers to unlock deeper analytical insights, improve productivity and accelerate biological discovery.
  • A seamless connection with the Thermo Scientific Ardia platform amplifies productivity and unlocks deeper insights into biotherapeutic characterization leading to safer biotherapies and vaccines.
  • New Thermo Scientific™ TraceFinder™ 5.2 SP1 software delivers innovative and flexible solutions for high throughput library screening and quantitation laboratories.
  • For more information on the Thermo Fisher solutions exhibited at ASMS 2023, please visit www.thermofisher.com/ASMS .

Thermo Fisher Scientific Introduces Groundbreaking Mass Spectrometer to Revolutionize Biological Discovery

Retrieved on: 
Monday, June 5, 2023
Science, Other Science, Other Manufacturing, Finance, Professional Services, Technology, Manufacturing, Other Technology, Astral, American Society for Mass Spectrometry, University, ASMS, Mass spectrometry, George R. Brown Convention Center, Cardiovascular disease, Cancer, TMO, Proteomics, Proteome, Multimedia, Research, Thermo Fisher Scientific, Genomics, Biomarker, Thermo, Laboratory, University of Washington Department of Global Health, Medicine, Health, Mindful Scientific Inc., Society, NYSE, Disease, Medical imaging, Orbitrap

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today unveiled the Thermo Scientific™ Orbitrap™ Astral™ mass spectrometer , one of the most significant advancements in mass spectrometry in 15 years.

Key Points: 
  • Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today unveiled the Thermo Scientific™ Orbitrap™ Astral™ mass spectrometer , one of the most significant advancements in mass spectrometry in 15 years.
  • Researchers can use this information to identify new clinical biomarkers, reveal diseases earlier and develop new interventions for everything from cardiovascular disease to cancer.
  • View the full release here: https://www.businesswire.com/news/home/20230605005016/en/
    The Thermo Scientific™ Orbitrap™ Astral™ mass spectrometer offers accurate and precise quantitation in proteomics laboratories with faster throughput, deeper coverage and higher sensitivity than the current state-of-the-art.
  • “The Orbitrap Astral mass spectrometer is a true gamechanger, offering an unrivaled combination of sensitivity, dynamic range and speed that doesn’t compromise accurate and precise quantitation.

Agilent Intelligent Mass Spectrometry Solutions to Inspire at ASMS 2023

Retrieved on: 
Friday, June 2, 2023
Technology, Biotechnology, Chemicals, Plastics, Health, Manufacturing, Other Science, Other Technology, Research, Medical Devices, Software, Hardware, Science, Other Manufacturing, Electronic Design Automation, ECD, Life, ASMS, Mass spectrometry, Deep learning, George R. Brown Convention Center, Intelligence, Automation, Marriott Marquis, Agilent Technologies, LC/MS, News, NYSE, Conference, HPLC, Management, Fine chemical

Agilent Technologies Inc. (NYSE: A) today announced new mass spectrometry solutions on show at the 71st ASMS Conference on Mass Spectrometry and Allied Topics , being held June 4 - 8 in Houston, Texas.

Key Points: 
  • Agilent Technologies Inc. (NYSE: A) today announced new mass spectrometry solutions on show at the 71st ASMS Conference on Mass Spectrometry and Allied Topics , being held June 4 - 8 in Houston, Texas.
  • Agilent is a global leader in the mass spectrometry market, providing advanced, intelligent instruments featuring improved analytical performance solutions for analytical labs worldwide.
  • “Agilent is leading the way in the trend towards developing more self-aware and intelligent instruments,” said Sudharshana Seshadri, vice president and general manager of Agilent’s Liquid Chromatography, Mass Spectrometry, and Automation Divisions.
  • The new Agilent 1260 Infinity II Hybrid Multisampler will be on show, an HPLC autosampler that offers classical Flow-through and Agilent Feed Injection modes.

Zebra Technologies to Celebrate Youth Engagement in STEM at FIRST® Championship

Retrieved on: 
Tuesday, April 18, 2023
Software, Technology, Robotics, Other Technology, FIRST Robotics Competition, Volunteering, Workforce, Learning, NFL, SatCon Technology Corporation, Zebra Technologies, RFID, Blue Alliance, George R. Brown Convention Center, AMRES, Science, technology, engineering, and mathematics, FRC, Student, FIRST, Sport, STEM, FIRST Championship, Transport, Interior design, Science, Engineering, Zebra

The FIRST Championship is the culminating international competition of the youth robotics community, FIRST® (For Inspiration and Recognition of Science and Technology).

Key Points: 
  • The FIRST Championship is the culminating international competition of the youth robotics community, FIRST® (For Inspiration and Recognition of Science and Technology).
  • Tens of thousands of students, volunteers and supporters from more than 43 countries are expected to attend the four-day event dedicated to celebrating youth engagement in Science, Technology, Engineering and Math (STEM).
  • “Beyond their support of the FIRST Championship, Zebra is a generous sponsor of FIRST.
  • “We are proud to support the next generation of STEM professionals as they gather in Houston to celebrate their innovations and achievements,” said Jeff Schmitz, Chief People Officer, Zebra Technologies.